Dr. Mark McClellan
Showing 1–2 of 2 transcripts.
- Goldman Sachs28 min
Protecting You, Your Family and Your Employees
Dr. Mark McClellan, Alex Gorsky, Dr. Susan David, John
Johnson & Johnson Chairman Alex Gorski, former FDA Commissioner Dr. Mark McClellan, and psychologist Dr. Susan David discuss a unified framework for navigating the intersection of the pandemic, racial justice, and economic stability. Gorski details Johnson & Johnson's accelerated vaccine development using its viral vector platform with a not-for-profit pricing model, while McClellan outlines a four-phase reopening strategy requiring robust healthcare capacity and equitable testing access. Concurrently, David argues that organizational resilience depends on leaders adopting emotional agility to validate employee distress and realigning systemic practices with core values to address the social inequities exposed by the crisis.
- Goldman Sachs28 min
Dr. Susan David, Alex Gorsky, and Dr. Mark McClellan
Dr. Susan David, Alex Gorsky, Dr. Mark McClellan, John
Johnson & Johnson CEO Alex Gorski, former FDA Commissioner Dr. Mark McClellan, and Dr. Susan David discuss leveraging emotional agility and industry-wide cooperation to address the compounding crises of the pandemic, economic disruption, and racial injustice. J&J details its accelerated vaccine development timeline, noting a pivot to viral vector technology that aims for human trials in July and a commitment to global not-for-profit distribution. Panelists further outline a four-phase reopening framework based on healthcare capacity and testing, while projecting permanent shifts toward preventive care models and concurrent clinical study phases.